Expect Aurobindo Pharma to test Rs 610-620: Mehta

Pritesh Mehta of IIFL is of the view that one may see more upside in Aurobindo Pharma and feels that the stock may test Rs 610-620 if it moves above Rs 570.

Pritesh Mehta of IIFL told CNBC-TV18, "I have been a big fan of Aurobindo Pharma  for a while now and for the last one month or so the stock has been consolidating at the top. It had a terrific rally in 2014. It has gone up by more than 40 percent and still looks attractive. Any kind of stock which consolidates at the top, one has to be part of that counter."

"Aurobindo Pharma has been consolidating between Rs 540-570 for last one month. So, any kind of move up from Rs 570 could see the stock attempting the levels of Rs 610-620. So, there is a good opportunity for more upside," he said.

Disclosure: Analyst might have recommended the stock to his clients, but has no personal holdings.

Anda sedang membaca artikel tentang

Expect Aurobindo Pharma to test Rs 610-620: Mehta

Dengan url

http://harmonisem.blogspot.com/2014/04/expect-aurobindo-pharma-to-test-rs-610.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Expect Aurobindo Pharma to test Rs 610-620: Mehta

namun jangan lupa untuk meletakkan link

Expect Aurobindo Pharma to test Rs 610-620: Mehta

sebagai sumbernya